BusinessMesofilter Combats Global Water and Air Pollution with Mesopaper™, a High-performance, Low-cost, Easy-to-use Paper FilterBy Nasdaq OMXMar 7, 2018, 1:00 PM UTC
BusinessMesofilter to Announce Breakthrough Filtration Material; Replaces Reverse Osmosis, Chemical Treatment and Other ProcessesBy Nasdaq OMXFeb 28, 2018, 4:00 PM UTC
BusinessBioLargo Inc. CEO, Dennis Calvert, Returns to Uptick Newswire’s “Stock Day” Podcast for a Company UpdateBy Nasdaq OMXFeb 1, 2018, 2:30 PM UTC
BusinessBioLargo Sets New Sales Records and Continues to Break Through Commercial BarriersBy Nasdaq OMXNov 14, 2017, 2:30 PM UTC
BusinessBioLargo's Medical Subsidiary Files 510(k) with FDA for its Novel Wound Care TechnologyBy Nasdaq OMXSep 28, 2017, 1:12 PM UTC
BusinessBioLargo CEO Dennis Calvert Elaborates on the Importance of its new Engineering Division and Financing to Accelerate CommercializationBy Nasdaq OMXSep 20, 2017, 2:00 PM UTC
BusinessBioLargo Acquires World-Class Engineering Team to Form a New Engineering Services Subsidiary and Enters into Common Stock Purchase Agreement for Up to $10 Million with Lincoln Park CapitalBy Nasdaq OMXSep 11, 2017, 1:30 PM UTC
BusinessBioLargo’s 3rd Annual Technical Symposium Showcases its Advanced Oxidation System (AOS) and First Commercial Validation Trials Performance ResultsBy Nasdaq OMXAug 22, 2017, 12:00 PM UTC
